CGE25-106: MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients

Emily Fogarty, Brian Corgiat, Kayla Sparks, Chris Arnell, Emanuel Petricoin, Justin Davis, Claudius Mueller

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	23
Issue number	35
DOIs	https://doi.org/10.6004/jnccn.2024.7183
State	Published - 28 Mar 2025
Externally published	Yes

Access to Document

@article{84c8d796e3ce44f689bb9c6ad91fcf3b,

title = "CGE25-106: MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients",

author = "Emily Fogarty and Brian Corgiat and Kayla Sparks and Chris Arnell and Emanuel Petricoin and Justin Davis and Claudius Mueller",

year = "2025",

month = mar,

day = "28",

doi = "10.6004/jnccn.2024.7183",

language = "English",

volume = "23",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "35",

}

TY - JOUR

T1 - CGE25-106

T2 - MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients

AU - Fogarty, Emily

AU - Corgiat, Brian

AU - Sparks, Kayla

AU - Arnell, Chris

AU - Petricoin, Emanuel

AU - Davis, Justin

AU - Mueller, Claudius

PY - 2025/3/28

Y1 - 2025/3/28

UR - http://www.scopus.com/inward/record.url?scp=105002540623&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.7183

DO - 10.6004/jnccn.2024.7183

M3 - Article

C2 - 40159128

AN - SCOPUS:105002540623

SN - 1540-1405

VL - 23

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 35

ER -